Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 37 Liver Neoplasms 18 Neoplasm Metastasis 17 Colorectal Neoplasms 13 Cholangiocarcinoma 11 Pancreatic Neoplasms 9 Lung Neoplasms 8 Colonic Neoplasms 8 Breast Neoplasms 8 Barrett Esophagus 7 Recurrence 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Thyroid Neoplasms 5 Rectal Neoplasms 5 Thyroid Nodule 4 Pain 4 Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Thyroid Cancer, Papillary 3 Biliary Tract Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Prostatic Neoplasms 2 Leiomyoma 2 Hyperaldosteronism 2 Cancer Pain 2 Bile Duct Neoplasms 2 Uterine Cervical Neoplasms 1

Interventions

Tamoxifen 4 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Letrozole 2 Cyclophosphamide 2 Control Groups 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Female × Radiofrequency Ablation × Clear all

NCT04389216 2025-09-15

RFA

Hospital Universitari de Bellvitge

Phase NA Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡